This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
In the April–June 2014 edition of Corporate Disputes, Group Vice President and Global Practice Leader Dr. Gregory Bell and other industry experts discuss pharma and biotech patent litigation.
Group Vice President and Life Sciences Practice Leader
Boston
+1-617-425-3357 gbell@crai.comIn this month’s IP Literature Watch we include an article analyzing four case studies of controversy over license design in open-source software and hardware...
In this month’s IP Literature Watch we include an article evaluating synthetic data and the future of artificial intelligence; a systematic literature review...
Dave Duski is a panelist during the session titled “Patent Damages: What is Really at Stake?” There are a variety of different types of damages that can be...
CRA is a proud sponsor of the event. Benno Buehler is a panelist during the session titled “New kinds of SEP Licensees.” For more information on this event,...
